Dexcom Investor
Dexcom's goal is to simplify and improve diabetes management by using Continuous Glucose Management (CGM). Designed to keep track of glucose levels.
Investors
Headquarters:
San Diego
Number Of Exists:
1
Total Funding:
413689019
Founded Date:
1999-05-22
Acquisitions Number:
3
Employee Number:
7600
Last Funding Type:
Post-IPO Debt
Investor Type:
For Profit
Investors Number:
7
Last Funding Date:
2017
Technology:
AgeTech
Funding Status:
IPO
Estimated Revenue:
US$ 3.62 billion
Industry:
manufacturing